All Posts: mind
-
Early-life Education Improves Memory in Old Age — Especially for Women
WASHINGTON (June 5, 2020) — Education appears to protect older adults, especially women, against memory loss, according to a study by investigators at Georgetown University Medical Center, published in the journal Aging, Neuropsychology, and Cognition. The results suggest that children — especially girls — who attend school for longer will have better memory abilities in […]
Category: News Release
-
Nilotinib Appears Safe and Affects Biomarkers in Alzheimer’s Disease Clinical Trial
WASHINGTON (May 29, 2020) — A Georgetown University Medical Center clinical trial investigating the cancer drug nilotinib in people with Alzheimer’s disease finds that it is safe and well-tolerated, and researchers say the drug should be tested in a larger study to further determine its safety and efficacy as a potential disease-modifying strategy. The results […]
Category: News Release
-
Georgetown’s José Merino Becomes Editor-In-Chief of the World’s Leading Clinical Neurology Journal
(April 18, 2020) — José G. Merino, MD, MPhil, FAHA, FAAN, professor of neurology at Georgetown University School of Medicine, became interested in medical journals as a medical student; he later gained experience in peer-reviewing journals as a fellow. Now, he will merge his longtime interest and extensive experience as he begins a 10-year term […]
Category: GUMC Stories
-
Zooming in on Brain Circuits Allows Researchers to Stop Seizure Activity
WASHINGTON (December 16, 2019) — A team of neuroscientists at Georgetown University Medical Center have found, in animal models, that they can “switch off” epileptic seizures. The findings, published online in Proceedings of the National Academy of Sciences (PNAS), provide the first evidence that while different types of seizures start in varied areas of the […]
Category: News Release
-
Nilotinib Appears Safe in Parkinson’s Trial; Drug Thought to Allow Dopamine Replenishment
WASHINGTON (December 16, 2019) — A clinical trial investigating the repurposed cancer drug nilotinib in people with Parkinson’s disease finds that it is reasonably safe and well tolerated. Researchers also report finding an increase in dopamine, the chemical lost as a result of neuronal destruction, and a decrease in neurotoxic proteins in the brain among […]
Category: News Release
-
Maguire-Zeiss Named New Chair of Department of Neuroscience
(August 29, 2019) — Since joining Georgetown’s faculty in 2007, Kathy Maguire-Zeiss, PhD, has taken on many roles. In addition to being a professor of neuroscience, she directs the Interdisciplinary Program in Neuroscience (IPN), the Center for Neural Injury and Recovery, the master’s degree program in integrative neuroscience and the T32 Training Program in Neural […]
Category: GUMC Stories
-
Shedding Light on Lewy Body Disease
(May 30, 2019) — Though many people are familiar with Parkinson’s and Alzheimer’s diseases, fewer have heard of Lewy body dementia, a neurodegenerative disorder with similar symptoms. “I think more awareness needs to be out there because Lewy body disease is probably just as prevalent as Parkinson’s,” said Fernando Pagan, MD (M’96), professor of neurology […]
Category: GUMC Stories
-
Georgetown University Launches Clinical Trial for Lewy Body Dementia
MEDIA CONTACT:(for members of the press only) Karen Teberkm463@georgetown.edu PATIENT INFORMATION:Joy Arellanomja6@gunet.georgetown.edu WASHINGTON (May 30, 2019) — Georgetown University Medical Center announces the launch of the only known therapeutic (disease modifying) clinical trial for Lewy body dementia, a neurological disorder that affects a million people in the United States for which there are no approved […]
Category: News Release
-
Why Adults at Risk for Huntington’s Disease Choose Not to Learn if They Inherited Deadly Gene
MEDIA CONTACT:Karen Teberkm463@georgetown.edu WASHINGTON (May 16, 2019) — As many as 90 percent of individuals who have a parent with Huntington’s disease (HD) choose not to take a gene test that reveals if they will also develop the fatal disorder — and a new study details the reasons why. Understanding the “why” matters as new […]
Category: News Release
-
Impacted by Parkinson’s Disease, Three Couples Plan to Leave a Lasting Legacy to Support Research
(April 26, 2019) — When someone is diagnosed with an incurable, life-changing disease like Parkinson’s, they usually have many questions about how it will affect their life and what can be done to manage it. Unfortunately, many people who have Parkinson’s symptoms don’t get those answers until they are fortunate enough to see a doctor […]
Category: GUMC Stories